Cypherpunk Swings to $39M Q2 Profit on $46M Zcash Gain, Eyes Sirexatamab Spin-Out
CYPH has more than doubled off its 52-week low of $0.232 on light trading volume (0.2× avg).
Summary
Cypherpunk Technologies posted a surprise Q2 profit of $39.4 million, or $0.18 per share, driven entirely by a $46 million unrealized gain on its Zcash holdings as the token surged from $243 to $400. The swing from a prior-year loss is a direct reflection of the company's crypto treasury strategy paying off. Meanwhile, R&D costs dropped sharply after a clinical trial wrapped and headcount was cut, and the company announced a strategic review for its sirexatamab program, including potential partnerships or a spin-out. With a market cap around $72 million, a $39 million quarterly profit is transformative, though the gain is unrealized and tied to volatile crypto prices. The sole analyst rates it a buy with a $0.90 target, implying further upside from the $0.68 close.
At the time of this announcement, CYPH was trading at $0.71 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $72.4M. The 52-week trading range was $0.23 to $3.70. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.